Download Citation
Article Source:
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis
Zakaria C,
Sean P,
Hoang HD,
Leroux LP,
Watson M,
et al.
(2018)
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
PLOS Pathogens 14(8): e1007264.
https://doi.org/10.1371/journal.ppat.1007264